NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study

NCT05059080

TerminatedN/A

Sponsor: Hoffmann-La Roche

Conditions: COVID-19, Long COVID

Countries: Argentina, Belgium, Brazil, Denmark, Germany, Mexico, Romania, Switzerland

This study will evaluate the long-term sequelae of COVID-19 in patients diagnosed with COVID-19 who previously enrolled in a RO7496998 (AT-527) study (i.e. parent study NCT04889040 \[CV43043\]), for approximately 6 months after the end of the parent study.

Eligibility overview

Sex: ALL

Age: 12 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Participant was diagnosed with COVID-19 and enrolled in a Phase III RO7496998 (AT-527) COVID-19 study

Exclusion Criteria:

* Participation in an interventional study at the time of enrollment or plans to enroll in an interventional study during this study.
* Any serious medical condition or abnormality of clinical laboratory tests that, in the investigator's judgment, precludes the patient's safe participation in and completion of the study

Locations (35)

Mar del Plata, Argentina
Erpent, Belgium
Gozée, Belgium
Brasília, Federal District, Brazil
Taguatinga, Federal District, Brazil
Curitiba, Paraná, Brazil
Recife, Pernambuco, Brazil
São Paulo, São Paulo, Brazil
Aalborg, Denmark
Copenhagen, Denmark
Roskilde, Denmark
Cologne, Germany
Torreón, Coahuila, Mexico
Guadalajara, Jalisco, Mexico
Mexico City, Mexico CITY (federal District), Mexico
Queréaro, Querétaro, Mexico
Guadalajara, Mexico
México, Mexico
Bucharest, Romania
Caracal, Romania
Sibiu, Romania
Zurich, Switzerland
Ankara, Turkey (Türkiye)
Ankara, Turkey (Türkiye)
Çankaya, Turkey (Türkiye)
Izmir, Turkey (Türkiye)
Trabzon, Turkey (Türkiye)
Ivano-Frankivsk, Katerynoslav Governorate, Ukraine
Kharkiv, Kharkiv Governorate, Ukraine
Dnipro, Kholm Governorate, Ukraine
+ 5 more on CT.gov